Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,General Medicine
Reference16 articles.
1. American Society for Colposcopy and Cervical Pathology. Updated consensus guidelines for managing abnormal cervical cancer screening tests and cancer precursors. https://www.asccp.org/Assets/51b17a58-7af9-4667-879a-3ff48472d6dc/635912165077730000/asccp-management-guidelines-august-2014-pdf. Reprinted August 2014. (Accessed 12 Dec 2019).
2. Choi JW, Kim Y, Lee JH, Kim YS (2016) The clinical performance of primary HPV screening, primary HPV screening plus cytology cotesting, and cytology alone at a tertiary care hospital. Cancer Cytopathol 124(2):144–152
3. Schiffman M, Kinney WK, Cheung LC et al (2018) Relative performance of HPV and cytology components of cotesting in cervical screening. Int Natl Cancer Inst 110(5):501–508
4. Bogani G, Taverna F, Lombardo C et al (2017) Retrospective study of the influence of HPV persistence on outcomes among women with high-risk HPV infections and negative cytology. Int J Gynaecol Obstet 138(1):62–68
5. Polman NJ, Veldhuijzen NJ, Heideman DAM, Snijders PJF, Meijer CJLM, Berkhof J (2019) Management of HPV-positive women in cervical screening using results from two consecutive screening rounds. Int J Cancer 144(9):2339–2346
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献